WP
EW icon

Woodline Partners’s Edwards Lifesciences EW Stock Holding History

Woodline Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141M Sell
1,560,062
-208,114
-12% -$17.4M 0.44% 39
2026
Q1 		$142M Buy
1,768,176
+697,542
+65% +$57.5M 0.54% 25
2025
Q4 		$91.3M Buy
1,070,634
+511,098
+91% +$41.9M 0.35% 53
2025
Q3 		$43.5M Sell
559,536
-460,443
-45% -$36M 0.2% 137
2025
Q2 		$79.8M Buy
1,019,979
+194,621
+24% +$14.5M 0.42% 41
2025
Q1 		$59.8M Buy
825,358
+814,917
+7,805% +$58.3M 0.39% 59
2024
Q4 		$773K Sell
10,441
-342,796
-97% -$24M 0.01% 792
2024
Q3 		$23.3M Buy
353,237
+87,159
+33% +$6.33M 0.2% 170
2024
Q2 		$24.6M Sell
266,078
-215,848
-45% -$19.1M 0.23% 137
2024
Q1 		$46.1M Buy
481,926
+180,214
+60% +$15.1M 0.42% 64
2023
Q4 		$23M Buy
+301,712
New +$21M 0.25% 123
2023
Q3 		– Sell
-578,141
Closed -$54.5M – 634
2023
Q2 		$54.5M Buy
578,141
+368,892
+176% +$32.1M 0.65% 38
2023
Q1 		$17.3M Buy
209,249
+160,931
+333% +$12.6M 0.24% 121
2022
Q4 		$3.61M Sell
48,318
-379,569
-89% -$29.3M 0.05% 370
2022
Q3 		$35.4M Buy
+427,887
New +$41.2M 0.49% 42
2022
Q2 		– Sell
-283,730
Closed -$33.4M – 824
2022
Q1 		$33.4M Buy
+283,730
New +$31.8M 0.54% 48
2021
Q3 		– Sell
-307,190
Closed -$31.8M – 703
2021
Q2 		$31.8M Buy
+307,190
New +$29M 0.59% 42
2020
Q2 		– Sell
-172,383
Closed -$10.8M – 162
2020
Q1 		$10.8M Buy
+172,383
New +$12.4M 0.77% 40

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Woodline Partners's EW Position: Q2 2026 in Review

Woodline Partners reduced its Edwards Lifesciences (EW) stake by 12% in Q2 2026, selling an estimated $17.4M and leaving 1,560,062 shares worth $141M. The position accounts for 0.44% of the portfolio, ranked #39.

Woodline Partners first reported a position in EW in Q1 2020 and has held it in 18 quarters since. The position peaked at $142M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Woodline Partners held 1,560,062 shares of Edwards Lifesciences worth $141M as of Q2 2026.
  • Woodline Partners sold 208,114 Edwards Lifesciences shares in Q2 2026, an estimated $17.4M.
  • Edwards Lifesciences made up 0.44% of Woodline Partners's portfolio in Q2 2026, its #39 holding.
  • Woodline Partners first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 18 quarters since.
  • Woodline Partners's Edwards Lifesciences position peaked at $142M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.